// App-Quantinova.ai

BSH2020‐PO‐066 : Unique differences in clinical presentation between JAK2 splanchnic vein thrombosis and WHO defined JAK2 myeloproliferative neoplasm

Researchers

Presenter

  • S. George

Principal Investigators

  • J. MacLeod

  • S. Francis

Medical Centers

  • Sheffield Teaching Hospitals NHS Trust, Royal Hallamshire Hospital, Sheffield, UK

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Nephrology

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

  • Oncology (ONC)

Disease

  • Myeloid neoplasms

  • Extrahepatic portal vein obstruction

  • Essential thrombocythemia

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • Hydroxycarbamide

  • Warfarin

  • Aspirin

  • Albyl-E

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved